Violation Tracker Individual Record
Date:August 6, 2014
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Pfizer agreed to pay $35 million as part of the settlement of multistate litigation alleging improper marketing and promotion of the immunosuppressive drug Rapamune.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:New York
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.